“Best Price” Or Better? Medicare/Medicaid Rules May Confuse Rebates
Executive Summary
CMS may need to intervene in Medicaid pharmacy reimbursement practices to ensure that the Medicare Part D program runs smoothly, Mintz Levin attorney Carolyn McElroy suggested Feb. 1 during CBI's Pharmaceutical Marketing Compliance Congress in Washington, D.C